openPR Logo
Press release

Cardiology Genomic Testing Market Critical Insights, Trends and Forecast till 2031

07-30-2021 09:43 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

Heart disorders can be inherited and passed from parents to children via their genes. Cardiology genomic testing helps in detecting diseases such as aortopathy and congenital heart diseases. Also, it can be useful for family members who are at a risk of developing heart problems. Genetic disorders affect the development of blood vessels and lead to heart diseases. Identification of genetic causes can save lives. The technology used for cardiology genomic testing is called NGS (Next generation Sequencing). The technology further reads the genetic content which helps in identifying the changes in DNA sequence. The mutations associated with heart conditions can occur due to pathogens.

Claim Sample Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=2565

Cardiology Genomic Testing Market: Drivers and Restraints

The growing prevalence of heart diseases such as cardiac arrhythmias and atherosclerosis is expected to be the major factor driving the growth of the cardiology genomic testing market over the forecast period. According to Invitae Corporation, more than 1 in 200 people have inherited some form of heart disease. Moreover, unhealthy lifestyle choices increase the risk of heart disease and this factor is driving the cardiology genomic testing market. Cardiology genomic testing helps in diagnosis, prognosis, and management of heart diseases. Cardiology genomic testing helps in identifying patients with a high risk of heart failure or arrhythmias. Also, the test differentiates and confirms the disease from other causes. Cardiology genomic testing also helps in directing treatment options which will avoid trigging cardiac events. Cardiology genomic testing kits provide rapid results and great efficiency. It also helps in reducing risks among patients. However, the number of genes vary with disorders. The overall cardiology genomic market testing is pushed by the growing expenditure on healthcare.

Cardiology Genomic Testing Market: Segmentation

Tentatively, the global cardiology genomic testing market can be segmented on the basis of sample type, type of testing and diagnosis, application, and end user.

Based on sample type, the global cardiology genomic testing market is segmented as:
Saliva
Blood
Cheek Swabs

Based on testing and diagnosis, the global cardiology genomic testing market is segmented as:
Genetic Screening
Pre-symptomatic Genetic Testing

Based on application, the global cardiology genomic testing market is segmented as:
Cardiomyopathies
Arrhythmias
Aortopathy
Other Cardiac Disorders

Based on end user, the global cardiology genomic testing market is segmented as:
Hospitals
Diagnostic Laboratories
Specialized Centers

Get Access to TOC Covering 200+ Topics @ https://www.factmr.com/connectus/sample?flag=T&rep_id=2565

Cardiology Genomic Testing Market: Overview

Cardiology genomic testing kits are used as a preventive healthcare diagnostic kit to save the lives of patients. According to the Center for Disease Control and Prevention, approximately 86 million people have at least one type of cardiovascular disease. Cardiology genomic testing kits are easy to use and the results are obtained within 4-8 weeks. The global market for cardiology genomic testing is expected to witness high growth over the forecast period. The cardiology genomic testing market is expected to increase with a rise in cardiac diseases among adults and children. Treatment is necessary for inherited and untreated heart conditions to further prevent serious problems such as heart attacks.

Cardiology Genomic Testing Market: Regional Outlook

Geographically, the global cardiology genomic testing market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan, and the Middle East and Africa (MEA). North America is expected to be the dominant market in the global cardiology genomic testing market owing to the increasing number of cardiac diseases. Also, the market in North America will rise due to the advancements in technology as well as strict regulations for patient care and safety in the region. The cardiology genomic testing market in the Asia Pacific excluding Japan is expected to grow at a significant CAGR due to the expansion of product offerings by the key players. In addition, cardiology genomic testing is contributing to the improvement of the health of the population by decreasing heart attack and congenital heart disease rates. Europe is expected to have the second largest share in the global cardiology genomic testing market throughout the forecast period.

Cardiology Genomic Testing Market: Key Players

The global market for cardiology genomic testing is highly fragmented. Examples of some of the key players operating in cardiology genomic testing kits are Color Genomics, Inc. Thermo Fisher Scientific, Admera Health, Helix OpCo LLC, Blueprint Genetics Oy. Illumina, Inc., Gnome Diagnostics, Creative Diagnostics, Merck KGaA, MP Biomedicals, LLC., CENTOGENE AG, and Oasis Diagnostics Corporation among others.

Share Your Requirements & Get Customized Reports @ https://www.factmr.com/connectus/sample?flag=RC&rep_id=2565

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cardiology Genomic Testing Market Critical Insights, Trends and Forecast till 2031 here

News-ID: 2342541 • Views:

More Releases from Fact.MR

Digital Twin Market is Growing at a CAGR of 34.3% d by 2033 | Key Players: ABB Ltd, ANSYS, Inc, AT&T Inc, AVEVA Group plc, Bentley Systems
Digital Twin Market is Growing at a CAGR of 34.3% d by 2033 | Key Players: ABB L …
Digital Twin Market is valued at USD 5 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 34.3%, reaching USD 95 billion by 2033. This explosive growth is driven by the increasing adoption of digital twins across industries to optimize operations, reduce costs, and enhance decision-making through virtual replicas of physical assets. Digital twins integrate IoT, AI, and data analytics to simulate real-world
Hemato Oncology Testing Market is Forecasted to Reach USD 23.64 Billion by 2033 | Fact.MR Report
09-02-2025 | Health & Medicine
Fact.MR
Hemato Oncology Testing Market is Forecasted to Reach USD 23.64 Billion by 2033 …
The global hemato oncology testing market is valued at USD 4.33 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 18.5%, reaching USD 23.64 billion by 2033. This rapid growth is driven by the increasing prevalence of blood-related cancers, such as lymphoma and leukemia, and advancements in diagnostic technologies like next-generation sequencing (NGS) and polymerase chain reaction (PCR). Hemato oncology testing plays a
Osseointegration Implants Market is Anticipated to Reach USD 6.85 Billion by 2035
09-02-2025 | Health & Medicine
Fact.MR
Osseointegration Implants Market is Anticipated to Reach USD 6.85 Billion by 203 …
Osseointegration Implants Market is poised for robust growth, with its valuation projected to rise from USD 3.17 billion in 2025 to USD 6.85 billion by 2035, reflecting a compound annual growth rate (CAGR) of 8%. This expansion is driven by the increasing prevalence of orthopedic and dental disorders, such as osteoarthritis, rheumatoid arthritis, and edentulism, which necessitate advanced implant solutions. Osseointegration implants, which fuse directly with bone to provide stable
Fibrin Sealants Market is Anticipated to Reach USD 1.92 Billion by 2033 | Fact.MR Report
09-02-2025 | Health & Medicine
Fact.MR
Fibrin Sealants Market is Anticipated to Reach USD 1.92 Billion by 2033 | Fact.M …
The global fibrin sealants market is valued at USD 976.5 million in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 7%, reaching USD 1.92 billion by 2033. This growth is driven by the increasing prevalence of surgical procedures requiring effective hemostasis and tissue sealing, particularly in cardiovascular, orthopedic, and general surgeries. Fibrin sealants, derived from human plasma proteins, mimic the body's natural clotting process,

All 5 Releases


More Releases for Cardiology

05-30-2025 | Health & Medicine
AltuMED
AltuMED Launches Expert Cardiology Billing Services For Cardiology Practices Acr …
BINGHAM FARMS, MI. - AltuMED today introduced specialized Cardiology Billing Services targeting revenue leakage in cardiovascular practices. The Michigan-based RCM innovator addresses critical challenges like complex CPT coding (93458, 93610), ICD-10 compliance (I25.10), and high denial rates that cause U.S. cardiology practices to lose $19B annually. Key solutions include: - AI-powered claim auditing achieving 98% accuracy - Real-time denial tracking reducing rejections by 40% - Custom workflows for cardiac diagnostics/interventions - CMS guideline-compliant billing protocols -
Cardiology Surgical And Interventional Cardiology Devices Market Size by Type, A …
USA, New Jersey- According to Market Research Intellect, the global Cardiology Surgical And Interventional Cardiology Devices market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period. The Cardiology Surgical and Interventional Cardiology Devices market is projected to grow at a CAGR of approximately 7.4% between 2025 and
Cardiology Stem Cells Market - Reviving the Beat: Cardiology Stem Cells Revoluti …
Newark, New Castle, USA: The "Cardiology Stem Cells Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Cardiology Stem Cells Market: https://www.growthplusreports.com/report/cardiology-stem-cells-market/8758 This latest report researches the industry structure,
Cardiology Conference 2022
Theme: "Exploring New Research and Frontiers in Heart Care" Heart 2022 welcomes all the eminent professional scholars, researchers and beloved students to be a part of this “INTERNATIONAL CONFERENCE ON CLINICAL CARDIOLOGY & CONGENITAL HEART DISEASE” scheduled on FEBRUARY 07-08, 2022 | PARIS | FRANCE. With individuals from around the world zeroed in on finding a few solutions concerning Cardiology, this is your single most clear chance to achieve the best
World Cardiology Congress
Herald Meetings welcomes you to join World Cardiology Congress scientific symposium will be held in Prague, Czech Republic during August 26 to 27, 2020 About Conferences: WORLD CARDIOLOGY CONGRESS, scheduled on August 26-27, 2020 at Prague, Czech Republic. The conference strives to provide meaningful coverage on the theme "Prediction, Prevention and Cure of Cardiovascular Diseases". Cardiology Congress has established itself as a significant forum for Professors, Cardiology Specialists, Eminent Scientists, and Vascular surgeons,
Cardiology Surgery, Devices and Drugs Market Report 2018: Segmentation by Type ( …
Global Cardiology Surgery, Devices and Drugs market research report provides company profile for St. Jude Medical, Cook Medical, C. R. Bard, Sun Pharmaceutical, Pfizer, Sanofi, AstraZeneca, Novartis, Bristol-Myers Squibb, Merck, Boston Scientific, Medtronic and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and